141 related articles for article (PubMed ID: 26255146)
41. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
42. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
Lau AH; Chow SS
Eur J Pharmacol; 2003 Mar; 464(2-3):229-35. PubMed ID: 12620517
[TBL] [Abstract][Full Text] [Related]
43. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.
Fan P
J Neurophysiol; 1995 Feb; 73(2):907-10. PubMed ID: 7760148
[TBL] [Abstract][Full Text] [Related]
44. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
45. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
FEBS Lett; 2005 Dec; 579(30):6885-9. PubMed ID: 16337199
[TBL] [Abstract][Full Text] [Related]
46. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum.
Kurjak M; Hamel AM; Allescher HD; Schusdziarra V; Storr M
Neuropeptides; 2008; 42(5-6):623-32. PubMed ID: 18829105
[TBL] [Abstract][Full Text] [Related]
47. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
48. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
49. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
50. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.
Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
[TBL] [Abstract][Full Text] [Related]
51. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
McAllister SD; Griffin G; Satin LS; Abood ME
J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
[TBL] [Abstract][Full Text] [Related]
52. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
53. Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.
Lisboa SF; Camargo LH; Magesto AC; Resstel LB; Guimarães FS
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1193-206. PubMed ID: 24438603
[TBL] [Abstract][Full Text] [Related]
54. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.
Van den Bossche I; Vanheel B
Br J Pharmacol; 2000 Sep; 131(1):85-93. PubMed ID: 10960073
[TBL] [Abstract][Full Text] [Related]
55. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
57. Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells.
Stanslowsky N; Jahn K; Venneri A; Naujock M; Haase A; Martin U; Frieling H; Wegner F
Addict Biol; 2017 Sep; 22(5):1329-1342. PubMed ID: 27027565
[TBL] [Abstract][Full Text] [Related]
58. AM630, a competitive cannabinoid receptor antagonist.
Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
[TBL] [Abstract][Full Text] [Related]
59. [Cannabinoid applications in glaucoma].
Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
[TBL] [Abstract][Full Text] [Related]
60. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
